Urology · Los Angeles, CA
NPI
1063510840
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
8635 W 3rd St Ste 1
Los Angeles, CA, 90048
Phone (310) 854-9898
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
87,224 services
Medicare patients, 2024
1,511
Average age 76
Drug cost, 2024
$1.5M
3,981 prescriptions
Company payments, 2025
$3,208
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David Josephson was code J1071 (injection, testosterone cypionate, 1 mg), 46,855 times for 17 patients. In total David Josephson billed 87,224 services in 180 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-06-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 46,855 | 17 | $0.02 | $856 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 5,700 | 56 | $0.10 | $586 |
| J9030 Bcg live intravesical instillation, 1 mg | Office | 4,552 | 20 | $2.21 | $10K |
| 99214 Office E&M - Established | Office | 1,687 | 1,120 | $87.20 | $147K |
| J3260 Injection, tobramycin sulfate, up to 80 mg | Office | 1,497 | 244 | $1.88 | $2,814 |
| 36415 Venipuncture Blood Collection | Office | 1,232 | 847 | $8.64 | $11K |
| 84153 Clinical Chemistry | Office | 1,224 | 817 | $18.00 | $22K |
| 84403 Clinical Chemistry | Office | 1,157 | 786 | $25.27 | $29K |
| 80069 Clinical Chemistry | Office | 921 | 676 | $8.50 | $7,831 |
| 85025 Blood Count | Office | 860 | 633 | $7.61 | $6,545 |
| 84270 Clinical Chemistry | Office | 812 | 598 | $21.30 | $17K |
| 82670 Clinical Chemistry | Office | 807 | 595 | $27.38 | $22K |
| 84154 Clinical Chemistry | Office | 797 | 614 | $18.00 | $14K |
| 76856 Ultrasound - Abdomen and Pelvis | Office | 790 | 612 | $80.88 | $64K |
| 80076 Clinical Chemistry | Office | 781 | 578 | $8.01 | $6,256 |
By year: 2022 $1.4M for 103,560 services; 2023 $1.7M for 86,230 services; 2024 $1.3M for 87,224 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,232 | 847 | $8.64 | $11K |
| 84153 Clinical Chemistry | 1,224 | 817 | $18.00 | $22K |
| 84403 Clinical Chemistry | 1,157 | 786 | $25.27 | $29K |
| 80069 Clinical Chemistry | 921 | 676 | $8.50 | $7,831 |
| 85025 Blood Count | 860 | 633 | $7.61 | $6,545 |
| 84270 Clinical Chemistry | 812 | 598 | $21.30 | $17K |
| 82670 Clinical Chemistry | 807 | 595 | $27.38 | $22K |
| 84154 Clinical Chemistry | 797 | 614 | $18.00 | $14K |
| 80076 Clinical Chemistry | 781 | 578 | $8.01 | $6,256 |
| 83036 Blood Count | 778 | 574 | $9.52 | $7,407 |
Medicare prescription drug claims, 2024
In 2024, the drug David Josephson prescribed most often to Medicare patients was Tamsulosin Hcl, with 843 prescriptions and refills. In total David Josephson wrote 3,981 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 843 | 1,776 | 226 | $13K |
| Finasteride Generic | 504 | 1,120 | 133 | $5,987 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 369 | 760 | 113 | $6,553 |
| Myrbetriq Mirabegron | 355 | 542 | 88 | $248K |
| Gemtesa Vibegron | 242 | 344 | 62 | $162K |
| Silodosin Generic | 155 | 323 | 45 | $14K |
| Testosterone Generic | 152 | 178 | 35 | $18K |
| Tadalafil Generic | 147 | 245 | 35 | $24K |
| Cefuroxime Cefuroxime Axetil | 120 | 120 | 100 | $918 |
| Dutasteride Generic | 99 | 179 | 21 | $2,996 |
| Xyosted Testosterone Enanthate | 91 | 109 | 18 | $67K |
| Anastrozole Generic | 66 | 140 | 16 | $427 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 55 | 55 | 42 | $1,067 |
| Testosterone Cypionate Generic | 50 | 99 | 20 | $2,277 |
| Xtandi Enzalutamide | 41 | 41 | Under 11 | $586K |
Brand drugs: 860 claims; generic drugs: 3,121 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David Josephson $3,208 ($3,208 in general payments such as food, travel and fees) from 18 companies. The largest payer was Intuitive Surgical, Inc. with $2,219.
| Company | Payments | Amount |
|---|---|---|
| Intuitive Surgical, Inc. ISRG | 4 | $2,219 |
| Laborie Medical Technologies Corp. | 4 | $201 |
| Janssen Biotech, Inc. JNJ | 5 | $112 |
| Teleflex LLC TFX | 3 | $110 |
| Telix Pharmaceuticals TLX | 3 | $100 |
| Ferring Pharmaceuticals Inc. | 5 | $94.01 |
| Pfizer Inc. PFE | 4 | $68.06 |
| Astellas Pharma US Inc 4503.T | 2 | $58.27 |
| Abbvie Inc. ABBV | 2 | $52.69 |
| Medtronic, Inc. MDT | 2 | $48.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.